Published January 1983
by Academic Press Inc.,U.S. .
Written in English
|The Physical Object|
|Number of Pages||616|
Although primary cutaneous γ/δ T-cell lymphoma characteristically show a TCRγδ +, βF1 − T-cell phenotype, expression of TCRγδ has also been found in rare cases of otherwise classic MF or LyP. 37,38 Such cases have the same indolent course as cases with an αβ T-cell phenotype, and should be diagnosed as MF or LyP, irrespective of Cited by: Tumors of the hematopoietic and lymphoid tissues (American English) or tumours of the haematopoietic and lymphoid malignancies (British English) are tumors that affect the blood, bone marrow, lymph, and lymphatic system. Because these tissues are all intimately connected through both the circulatory system and the immune system, a disease affecting one will often affect . A neoplasm (/ ˈ n iː oʊ p l æ z əm, ˈ n i ə-/) is a type of abnormal and excessive growth, called neoplasia, of growth of a neoplasm is uncoordinated with that of the normal surrounding tissue, and it persists growing abnormally, even if the original trigger is lty: Oncology. Germ cell neoplasia in situ (GCNIS) of the testis is the WHO-recommended term for precursor lesions of invasive germ cell tumours, and testicular germ cell tumours are now separated into two fundamentally different groups: those derived from GCNIS and those unrelated to by:
The brain tumor microenvironment (TME) is emerging as a critical regulator of cancer progression in primary and metastatic brain malignancies. The unique properties of this organ require a specific framework for designing TME-targeted interventions. Here, we discuss a number of these distinct features, including brain-resident cell types, the blood-brain barrier, and various Cited by: Adoptive cell therapy with genetically modified T cells holds the promise to improve outcomes for children with recurrent/refractory solid tumors and has the potential to reduce treatment complications for all patients. Although T cells that express chimeric antigen receptors (CARs) specific for CD19 have had remarkable success for B-cell–derived Cited by: 5. In contrast to B‐cell lymphomas, most T‐cell lymphomas lack defining genetic alterations, and its classification relies on a combination of morphological and immunophenotypical features. 1 The recognition that T‐cell lymphomas are related to the innate and adaptive immune system, as well as enhanced understanding of T‐cell subsets such Cited by: 7. B-cell lymphomas are malignant tumours of B-lymphocytes. They arise at all stages of B-cell differentiation, from immature B-lymphocytes in the bone-marrow through to terminally differentiated plasma cells (Fig. 1). It is now possible to use immunogenetic analyses to define more clearly the cell origin and clonal history of B-cell tumours.
WHO Classification: Tumours of the Haematopoietic and Lymphoid Tissues () Book Editor(s): mature T‐cell and NK‐cell neoplasms, Hodgkin lymphoma, histiocytic and dendritic cell neoplasms and post‐transplant lymphoproliferative disorders. Citing Literature. In September , an updated version of the WHO-EORTC was published in the fourth edition of the WHO Classification of Skin Tumours Blue Book. In this classification, primary cutaneous acral CD8+ T-cell lymphoma and Epstein-Barr virus positive (EBV+) mucocutaneous ulcer are included as new provisional entities, and a new section on cutaneous Cited by: Mesenchymal tumours Secondary tumours 5 Tumours of the ampullary region WHO and TNM classifications Adenomas and other premalignant neoplastic lesions Invasive adenocarcinoma Neuroendocrine neoplasms 6 Tumours of the small intestine WHO and TNM classifications Carcinoma Neuroendocrine neoplasms B-cell lymphoma T-cell lymphoma Mesenchymal tumours. B and T cell tumors. New York: Academic Press, (OCoLC) Online version: Symposium on B and T Cell Tumors: Biological and Clinical Aspects ( Squaw Valley, Calif.). B and T cell tumors. New York: Academic Press, (OCoLC) Material Type: Conference publication: Document Type: Book: All Authors / Contributors.